Hill-Rom (HRC) 10-Q 5 Feb 21 2021 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Dec. 31, 2020	Jul. 29, 2020
Document And Entity Information Abstract
Document Type	10-Q
Title of 12(b) Security	Common Stock, without par value
Entity Shell Company	false
Entity Interactive Data Current	Yes
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2020
Document Transition Report	false
Entity File Number	1-6651
Entity Registrant Name	HILL-ROM HOLDINGS, INC.
Entity Incorporation, State or Country Code	IN
Entity Tax Identification Number	35-1160484
Entity Address, State or Province	IL
Entity Address, City or Town	Chicago
Entity Address, Postal Zip Code	60601
Trading Symbol	HRC
Security Exchange Name	NYSE
Amendment Flag	false
Entity Central Index Key	0000047518
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		66,362,046
Entity Emerging Growth Company	false
Entity Small Business	false
Document Information [Line Items]
Entity Voluntary Filers	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Product sales and service revenue	$ 652,500,000	$ 614,300,000
Rental revenue	88,600,000	70,700,000
Revenues	741,100,000	685,000,000
Total cost of net revenue (excludes acquisition-related intangible asset amortization)	324,200,000	306,300,000
Rental expenses	37,700,000	37,000,000
Cost of Revenue	361,900,000	343,300,000
Research and development expenses	34,800,000	31,500,000
Selling and administrative expenses	209,000,000	196,800,000
Amortization of Intangible Assets	25,900,000	26,700,000
Special charges	27,100,000	7,800,000
Operating Profit	82,400,000	78,900,000
Interest expense	(17,800,000)	(19,400,000)
Gain (Loss) on Extinguishment of Debt	0	(15,600,000)
Investment income (expense) and other, net	7,000,000	(1,300,000)
Income Before Income Taxes	71,600,000	42,600,000
Income Tax Expense (Benefit)	12,800,000	2,800,000
Net Income	$ 58,800,000	$ 39,800,000
Net Income Attributable to Common Shareholders per Common Share - Basic (usd per share)	$ 0.88	$ 0.60
Earnings Per Share, Diluted	$ 0.88	$ 0.59
Average Common Shares Outstanding - Basic (thousands) (Note 10) (in shares)	66,497	66,792
Average Common Shares Outstanding - Diluted (thousands) (Note 10) (in shares)	66,925	67,329

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Statement of Comprehensive Income [Abstract]
Net Income	$ 58.8	$ 39.8
Other Comprehensive (Loss) Income, net of tax (Note 7):
Derivative instruments designated as hedges	(4.9)	(2.6)
Foreign currency translation adjustment	41.3	23.1
Change in pension and postretirement defined benefit plans	0.5	0.7
Other Comprehensive Income (Loss), Net of Tax, Total	36.9	21.2
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$ 95.7	$ 61

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Dec. 31, 2020	Sep. 30, 2020
Current Assets
Cash and cash equivalents	$ 294,600,000	$ 296,500,000
Trade accounts receivable, net of allowances of $27.7 and $25.9 as of December 31, 2020 and September 30, 2020	598,000,000	594,900,000
Inventory, Net	335,900,000	352,000,000
Other current assets	111,500,000	121,500,000
Total current assets	1,340,000,000	1,364,900,000
Property, plant and equipment	878,100,000	858,200,000
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	(569,600,000)	(552,100,000)
Property, Plant and Equipment, Net	308,500,000	306,100,000
Goodwill	1,847,900,000	1,835,500,000
Other intangible assets and software, net	958,600,000	976,700,000
Deferred Income Tax Assets, Net	34,700,000	32,900,000
Other assets	153,800,000	155,000,000
Assets	4,643,500,000	4,671,100,000
Current Liabilities
Trade accounts payable	202,900,000	236,500,000
Short-term borrowings	222,300,000	222,300,000
Accrued compensation	97,600,000	144,900,000
Accrued product warranties	30,000,000	30,800,000
Accrued rebates	54,400,000	44,800,000
Deferred Revenue	112,300,000	110,100,000
Other current liabilities	180,700,000	162,800,000
Total current liabilities	900,200,000	952,200,000
Long-term debt	1,643,800,000	1,655,700,000
Accrued pension and postretirement benefits	94,700,000	89,300,000
Deferred Income Tax Liabilities, Net	108,700,000	113,000,000
Other long-term liabilities	133,000,000	134,800,000
Total Liabilities	2,880,400,000	2,945,000,000
SHAREHOLDERS' EQUITY
Common Stock, Value, Issued	4,400,000	4,400,000
Additional paid-in capital	668,500,000	667,000,000
Retained earnings	2,174,100,000	2,132,200,000
Accumulated other comprehensive income (loss)	(143,300,000)	(180,200,000)
Treasury stock, common shares at cost: 22,103,626 as of December 31, 2020 and 21,816,802 as of September 30, 2020	(940,600,000)	(897,300,000)
Total Shareholders’ Equity	1,763,100,000	1,726,100,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	1,763,100,000	1,726,100,000
Total Liabilities and Shareholders' Equity	4,643,500,000	4,671,100,000
Allowance for possible losses and discounts on trade receivables	$ 27.7	$ 25.9
Shares authorized	1,000,000
Common Stock, Shares Authorized	199,000,000
Common Stock, Shares, Issued	88,457,634
Common Stock, Shares, Outstanding	66,354,008	66,640,832
Treasury Stock, Common, Shares	22,103,626	21,816,802

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Operating Activities
Net Income (Loss) Attributable to Parent	$ 58.8	$ 39.8
Adjustments to reconcile net income to net cash, cash equivalents and restricted cash provided by operating activities:
Depreciation and Amortization of PP&E and Software	18.4	16.6
Acquisition-related intangible asset amortization	25.9	26.7
Amortization of Debt Issuance Costs and Discounts	1.1	1
Gain (Loss) on Extinguishment of Debt	0	15.6
Benefit for deferred income taxes	(3.3)	(3.9)
Loss on disposal of property, equipment, intangible assets and impairments	0.1	1.1
Stock compensation	11	8.3
Other Operating Activities, Cash Flow Statement	4.5	(5.1)
Change in working capital excluding cash, current debt, acquisitions and dispositions:
Trade accounts receivable	(6.2)	(74.8)
Inventories	(15.4)	9.8
Other current assets	(9.7)	15.8
Trade accounts payable	(35.7)	(9)
Accrued expenses and other liabilities	(16.1)	(60.2)
Increase (Decrease) in Accounts Receivable	6.2	74.8
Increase (Decrease) in Inventories	15.4	(9.8)
Increase (Decrease) in Other Operating Assets	9.7	(15.8)
Increase (Decrease) in Accounts Payable, Trade	(35.7)	(9)
Accrued expenses and other liabilities	(16.1)	(60.2)
Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net	4.2	(3.1)
Net Cash Provided by (Used in) Operating Activities, Total	100.2	77
Investing Activities
Purchases of property, plant, equipment and software	(29.3)	(24.3)
Proceeds on sale of property and equipment	0.3	0.5
Net Cash Provided by (Used in) Investing Activities	(29)	(23.8)
Financing Activities
Repayments of Long-term Debt	(12.5)	(12.6)
Borrowings on Revolving Credit Facility	0	(50)
Payments on Revolving Credit Facility	0	(55)
Payments on Securitization Facility	0	(7.5)
Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement	0	11.4
Payments on Note Securitization Facility	0	(12.6)
Payment for Debt Extinguishment or Debt Prepayment Cost	0	(437.2)
Cash dividends	(14.6)	(14.1)
Proceeds on exercise of stock options	0.5	3.7
Payment, Tax Withholding, Share-based Payment Arrangement	(8.3)	(15.1)
Payments for Repurchase of Common Stock	(47.4)	0
Proceeds from (Payments for) Other Financing Activities	2.3	1.7
Net Cash Provided by (Used in) Financing Activities, Total	(80)	(487.3)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	6.9	4.7
Net Cash Flows	(1.9)	(429.4)
Cash, Cash Equivalents and Restricted Cash:
At beginning of period	296.5	633.8
At end of period	$ 294.6	$ 204.4

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Shareholders' Equity (unaudited) Statement - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Treasury Stock [Member]
Common Stock, Shares, Outstanding, Beginning Balance at Sep. 30, 2019		88,457,634
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Sep. 30, 2019	$ 1,573,300,000	$ 4,400,000	$ 637,400,000	$ 1,967,400,000	$ (182,500,000)	$ (853,400,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
New Accounting Standard Adjustment | Accounting Standards Update 2016-13 [Member]				800,000
Net Income (Loss) Attributable to Parent	39,800,000			39,800,000
Other Comprehensive Income (Loss), Net of Tax	21,200,000				21,200,000
Dividends	(14,100,000)			(14,100,000)
Payment, Tax Withholding, Share-based Payment Arrangement	(15,100,000)					(15,100,000)
Payments for Repurchase of Common Stock	0
Share-based Payment Arrangement, Increase for Cost Recognition	8,300,000		8,300,000
Stock Issued During Period, Value, Stock Options Exercised	(3,700,000)		(1,100,000)			(2,600,000)
Stock Issued During Period, Value	0		(15,400,000)			15,400,000
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 1,900,000		1,300,000			600,000
Other Comprehensive Income (Loss), Tax					(400,000)
Common Stock, Dividends, Per Share, Cash Paid	$ 0.21
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Dec. 31, 2019	$ 1,619,000,000	$ 4,400,000	632,700,000	1,993,100,000	(161,300,000)	(849,900,000)
Common Stock, Shares, Outstanding, Beginning Balance at Sep. 30, 2020	66,640,832	88,457,634
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Sep. 30, 2020	$ 1,726,100,000	$ 4,400,000	667,000,000	2,132,200,000	(180,200,000)	(897,300,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
New Accounting Standard Adjustment | Accounting Standards Update 2016-13 [Member]	(2,200,000)			(2,200,000)
Net Income (Loss) Attributable to Parent	58,800,000			58,800,000
Other Comprehensive Income (Loss), Net of Tax	36,900,000				36,900,000
Dividends	(14,600,000)		100,000	(14,700,000)
Payment, Tax Withholding, Share-based Payment Arrangement	(8,300,000)					(8,300,000)
Payments for Repurchase of Common Stock	(47,400,000)					(47,400,000)
Share-based Payment Arrangement, Increase for Cost Recognition	10,700,000		10,700,000
Stock Issued During Period, Value, Stock Options Exercised	(500,000)		(200,000)			(300,000)
Stock Issued During Period, Value	0		(11,000,000)			11,000,000
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 2,600,000		1,500,000			1,100,000
Other Comprehensive Income (Loss), Tax					(1,300,000)
Common Stock, Dividends, Per Share, Cash Paid	$ 0.22
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Dec. 31, 2020	$ 1,763,100,000	$ 4,400,000	$ 668,500,000	$ 2,174,100,000	$ (143,300,000)	$ (940,600,000)

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Nature of Operations	Hill-Rom Holdings, Inc. (the “Company,” “Hillrom,” “we,” “us,” or “our”) was incorporated on August 7, 1969, in the State of Indiana and is headquartered in Chicago, Illinois. We are a global medical technology leader whose approximately 10,000 employees have a single purpose: enhancing outcomes for patients and their caregivers by Advancing Connected Care™. Around the world, our innovations touch over 7 million patients each day. Our products and services help enable earlier diagnosis and treatment, optimize surgical efficiency and accelerate patient recovery while simplifying clinical communication and shifting care closer to home. We make these outcomes possible through digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, advanced equipment for the surgical space and more, delivering actionable, real-time insights at the point of care.
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the SEC for interim unaudited Condensed Consolidated Financial Statements. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete Condensed Consolidated Financial Statements. In the opinion of management, all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying Condensed Consolidated Financial Statements to present fairly the results of the interim periods presented. Quarterly results are not necessarily indicative of annual results. The unaudited Condensed Consolidated Financial Statements appearing in this Quarterly Report on Form 10-Q should be read in conjunction with the audited Condensed Consolidated Financial Statements and notes thereto included in Hillrom’s fiscal 2020 Form 10-K as filed with the SEC. The Condensed Consolidated Financial Statements include the accounts of Hillrom and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. The Company makes a number of significant estimates, assumptions, and judgments in the preparation of its financial statements. Additionally, the Company measures and classifies fair value measurements in accordance with the level hierarchy in conformity with GAAP. As of December 31, 2020, the Company's significant accounting policies and estimates and valuation techniques used to measure fair value have not changed from September 30, 2020. See Note 1. Summary of Significant Accounting Policies within the 2020 Form 10-K for the fiscal year ended September 30, 2020 for further information. Revenue Recognition — Sales and Rentals Disaggregation of Revenue The Company disaggregates revenue recognized from contracts with customers by geography and reportable segments consistent with the way in which management operates and views the business. See Note 11. Segment Reporting for the presentation of the Company's revenue disaggregation. Contract Balances Contract liabilities represent deferred revenues that arise as a result of cash received from customers at inception of contracts or where the timing of billing for services precedes satisfaction of our performance obligations. Such remaining performance obligations represent the portion of the contract price for which work has not been performed and are primarily related to our installation and service contracts. These contract liabilities are recorded in Deferred revenue and Other long-term liabilities. We expect to satisfy the majority of the remaining performance obligations and recognize revenue related to installation and service contracts within 12 to 24 months. The nature of our products and services does not give rise to contract assets as we typically do not have instances where a right to payment for goods and services already transferred to a customer exists that is conditional on something other than the passage of time. The following table summarizes contract liability activity for the three months ended December 31, 2020. The contract liability balance represents the transaction price allocated to the remaining performance obligations. Contract Liabilities Balance as of October 1, 2020 $ 138.1 New revenue deferrals 99.0 Revenue recognized upon satisfaction of performance obligations (97.2) Foreign currency translation adjustment 1.3 Balance as of December 31, 2020 $ 141.2 Rental Revenue We make certain products available to customers under short-term lease arrangements. Rental usage of these products is provided as an alternative to product sales and is short-term in nature. Products primarily include smart beds, including, but not limited to, bariatric, intensive care unit, maternity, and home care beds, as well as surfaces. These lease arrangements provide our customers with our products during periods of peak demand or often times for specialty purposes. Additionally, we provide wearable, non-invasive ventilation products to patients covered by monthly medical insurance reimbursements, which are considered month-to-month leasing arrangements. Income arising from these lease arrangements where we are the lessor is recognized within Rental revenue. We accounted for these lease arrangements as operating leases. Warranties and Guarantees We routinely grant limited warranties on our products with respect to defects in material and workmanship. The terms of these warranties are generally one year; however, certain components and products have substantially longer warranty periods. We recognize a reserve with respect to these obligations at the time of product sale, with subsequent warranty claims recorded directly against the reserve. The amount of the warranty reserve is determined based on historical trend experience for the covered products. For more significant warranty-related matters, which might require a field corrective action, separate reserves are established when such events are identified and the cost of correction can be reasonably estimated. In the normal course of business, we enter into various other guarantees and indemnities in our relationships with suppliers, service providers, customers, business partners and others. Examples of these arrangements would include guarantees of product performance, indemnifications to service providers and indemnifications of our actions to business partners. These guarantees and indemnifications have not historically had a material impact on our financial condition or results of operations, nor do we expect them to although indemnifications associated with our actions generally have no dollar limitations. In conjunction with our acquisition and divestiture activities, we entered into select guarantees and indemnifications of performance with respect to the fulfillment of our commitments under applicable purchase and sale agreements. The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract. With respect to divestitures, we also routinely enter into non-competition agreements for varying periods of time. Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have an adverse impact on our Condensed Consolidated Financial Statements. The following summarizes accrued product warranty activity for the three months ended December 31, 2020: Three Months Ended December 31 2020 Balance as of beginning of period $ 30.8 Provision for warranties in the period 5.4 Warranty claims in the period (6.4) Foreign currency translation adjustment 0.2 Balance as of end of period $ 30.0 Government Programs Related to COVID-19

Supplementary Balance Sheet Inf

Supplementary Balance Sheet Information	3 Months Ended
	Dec. 31, 2020
Balance Sheet Related Disclosures [Abstract]
Supplementary Balance Sheet Information	Supplementary Financial Statement Information December 31, September 30, 2020 Inventories, net of reserves: Finished products $ 156.1 $ 167.6 Work in process 51.7 48.4 Raw materials 128.1 136.0 Total inventories, net of reserves $ 335.9 $ 352.0 Accumulated amortization of software and other intangible assets $ 703.6 $ 667.3 Investments included in Other assets $ 50.5 $ 49.0 Supplemental Cash Flow Information Three Months Ended 2020 2019 Non-cash operating activities Operating cash flows paid for amounts included in the measurement of lease liabilities $ 7.0 $ 7.1 Non-cash investing activities: Change in capital expenditures not paid $ (4.2) $ (1.8) Non-cash financing activities: Distribution of shares issued under stock-based compensation plans $ 31.7 $ 25.1 Non-cash investing and financing activities: Right of use assets obtained in exchange for new lease liabilities $ 1.8 $ 6.5

Acquisitions

Acquisitions	3 Months Ended
	Dec. 31, 2020
Business Combinations [Abstract]
Acquisitions	Business Combinations Acquisitions Assets acquired and liabilities assumed in a business combination are recorded at their estimated fair values on the date of acquisition. The difference between the purchase price amount and the net fair value of assets acquired and liabilities assumed is recognized as goodwill on the balance sheet if the purchase price exceeds the estimated net fair value or as a bargain purchase gain on the income statement if the purchase price is less than the estimated net fair value. The allocation of the purchase price may be modified up to one year after the acquisition date as more information is obtained about the fair value of assets acquired and liabilities assumed. During fiscal 2020 we acquired the following companies: Company Name Description of the Business Description of the Acquisition Excel Medical Clinical communications software company located in the United States Purchased all of the outstanding equity interest. Connecta Clinical communications software company based in Mexico. Purchased the multiplatform medical device integration and connectivity software programs, products, and solutions of the company. Videomed Developer of integrated video solutions in operating rooms located in Italy. Purchased all of the outstanding equity interest. The purchase price for the acquisitions listed above includes contingent consideration for which the performance periods have not yet expired. For the three months ended December 31, 2020, we recorded a reduction in the contingent consideration obligations of $1.7 million in Selling and administrative expenses primarily related to Excel Medical as a certain commercial milestone was not met. The related contingent consideration liabilities are included in Other current liabilities and Other long-term liabilities. For the three months ended December 31, 2020, we did not close on any new acquisitions. For additional information on Acquisitions, see Note 3. Business Combinations within the 2020 Form 10-K. Bardy Diagnostics, Inc. On January 15, 2021, we entered into a definitive merger agreement with Bardy Diagnostics, Inc. (“Bardy”), a Delaware company that develops and delivers cardiac arrhythmia monitoring devices, for initial cash consideration of $375.0 million, subject to closing conditions and certain post-closing adjustments. Additionally, contingent consideration will be payable based on the revenue generated from the acquired cardiac monitoring product during the first two calendar years starting with the calendar year in which the transaction is closed. The contingent consideration payable for the first calendar year in which the transaction closes will equal 50% of the revenue generated if less than $45.0 million, 100% of revenue generated if between $45.0 million and $57.0 million, and 150% of revenue generated if greater than $57.0 million during calendar year 2021. The contingent consideration payable for the second calendar year will equal 50% of the revenue generated if less than $70.0 million, 100% of the revenue generated if between $70.0 million and $89.0 million, and 125% of the revenue generated if greater than $89.0 million during the calendar year 2022. On January 29, 2021, the Medicare Administrative Contractor, Novitas Solutions, published newly established, Category 1 reimbursement rates applicable to the Current Procedural Terminology ("CPT") codes for the extended holter cardiac monitoring category, including CPT codes 93241, 93243, 93245 and 93247. Hillrom is currently assessing the recent reimbursement rate decision and the potential impacts of that decision on the Bardy busines s. Asset Acquisition On January 28, 2021, we acquired the contact-free continuous monitoring intellectual property and technology from EarlySense Ltd. in exchange for cash of $30.0 million, a portion of our non-marketable equity investment in EarlySense Ltd. of $25.5 million and forgiveness of a prepayment of approximately $2.0 million. The investment will be transferred to EarlySense Ltd. at a future date upon the satisfaction of certain conditions outlined in the purchase agreement. Additionally, contingent consideration of up to $10.0 million will be payable if commercial milestones defined in the purchase agreement are achieved through September 2023. The intangible asset acquired will be presented in Other intangible assets and software, net.

Financing Agreements

Financing Agreements	3 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Financing Agreements	Financing Agreements Short-Term Borrowings Securitization Facilities We have our 364-day accounts receivable securitization progra m (the " Securitization Facility ") with certain financial institutions for borrowings up to $110.0 million. Additionally, we have our 364-day facility for borrowings up to $90.0 million (the " Note Securitization Facility"). Both facilities mature in April 2021. As of December 31, 2020, outstanding borrowings were $82.2 million on the Securitization Facility and $90.0 million on the Note Securitization Facility. See Note 5. Financing Agreements within the 2020 Form 10-K for the fiscal year ended September 30, 2020 for further information. Long-Term Debt As of December 31, 2020 and September 30, 2020, there were no outstanding borrowings on the Revolving Credit Facility, and available borrowing capacity was $1,191.0 million after giving effect to the $9.0 million of outstanding standby letters of credit. Long-Term Debt Redemption On October 7, 2019, we redeemed the senior unsecured 5.75% notes due September 2023 for $425.0 million and paid the prepayment premium of $12.2 million using the net proceeds from the senior unsecured 4.375% notes of $425.0 million maturing September 2027 that were issued in September 2019, along with funds borrowed from the Revolving Credit Facility. For the three months ended December 31, 2019, we recorded a loss on extinguishment of debt of $15.6 million, which was comprised of a $12.2 million prepayment premium and $3.4 million of debt issuance costs previously capitalized. See Note 5. Financing Agreements included within our 2020 Form 10-K for the fiscal year ended September 30, 2020 for further information. Fair Value The fair value of our debt is estimated based on the quoted market prices for the same or similar issues or on the current rates offered to us for debt of the same remaining maturities. The book values of our Securitization Facility, Note Securitization Facility, Term Loan A facility (“TLA Facility”) maturing in August 2024, and Revolving Credit Facility approximate fair value . The estimated fair values of our long-term debt instruments are described in the table below: December 31, September 30, 2020 Senior unsecured 5.00% notes due on February 15, 2025 $ 309.3 $ 310.1 Senior unsecured 4.375% notes due on September 15, 2027 450.0 441.2 Unsecured debentures 47.9 48.0 Total $ 807.2 $ 799.3 The estimated fair values of our long-term unsecured debentures were based on observable inputs such as quoted prices in markets that are not active. The estimated fair values of the Senior Notes were based on quoted prices for similar liabilities. These fair value measurements were classified as Level 2. Debt Covenants As of December 31, 2020, we were in compliance with all debt covenants under our financing agreements.

Derivatives

Derivatives	3 Months Ended
	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities Disclosure [Text Block]	Derivative Instruments and Hedging Activity We are exposed to various market risks, including fluctuations in interest rates and variability in foreign currency exchange rates. We have established policies, procedures, and internal processes governing our management of market risks and the use of financial instruments to manage our exposure to such risks. We employ cash flow hedges, net investment hedges, and other derivative instruments not designated for hedge accounting to manage these risks. Cash Flow Hedges To manage our exposure to market risk from fluctuations in interest rates, we enter into interest rate swaps that are designated as cash flow hedges. As of December 31, 2020 and September 30, 2020, we had interest rate swap agreements with an aggregate notional amount of $750.0 million to hedge the variability of cash flows through August 2024 associated with a portion of the variable interest rate payments on outstanding borrowings under our Senior Credit Agreement. We are subject to variability in foreign currency exchange rates due to our international operations. We enter into currency exchange contracts that are designated as cash flow hedges to manage our exposure arising from fluctuating exchange rates related to specific and projected transactions. We operate this program pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes. The sensitivity of earnings and cash flows to variability in exchange rates is assessed by applying an appropriate range of potential rate fluctuations to our assets, obligations, and projected results of operations denominated in foreign currencies. Our currency risk consists primarily of foreign currency denominated firm commitments and projected foreign currency denominated intercompany and third-party transactions. As of December 31, 2020 and September 30, 2020, the notional amount of outstanding currency exchange contracts was $42.2 million and $64.4 million, respectively. The maximum length of time over which we hedge transaction exposures is generally 12 months. Derivative gains and losses, initially reported as a component of Accumulated other comprehensive income (loss), are reclassified to earnings in the period when the underlying transaction affects earnings. Net Investment Hedges As of December 31, 2020, we had cross-currency swap agreements, with an aggregate notional amount of $198.3 million, to hedge the variability of net assets due to changes in the U.S. dollar-Euro spot exchange rates through July 2023. These cross-currency swaps are designated as net investment hedges of subsidiaries using the Euro as their functional currency. We assess hedge effectiveness under the spot-to-spot method and record changes in fair value attributable to the translation of foreign currencies through Accumulated other comprehensive income (loss). We amortize the impact of all other changes in fair value of the derivatives through Interest expense, which was an income of $1.3 million for both the three months ended December 31, 2020 and 2019. Undesignated Derivative Instruments We use forward contracts to mitigate the foreign exchange revaluation risk associated with recorded monetary assets and liabilities that are denominated in a non-functional currency. These derivative instruments are not formally designated as hedges and the terms of these instruments generally do not exceed one month. As of December 31, 2020 and September 30, 2020, we had forward contracts not designated as hedges with aggregate notional amounts of $157.5 million and $169.9 million, respectively. The following table summarizes unrealized and realized gains and losses for forward contracts not designated as hedges, which are recorded in Investment income (expense) and other, net. Three Months Ended December 31 2020 2019 Unrealized gain $ 0.5 $ 0.2 Realized gain 2.1 0.4 Fair Value We classify fair value measurements on our derivative instruments as Level 2. The estimated fair values of our derivative instruments are described in the table below: Derivative Instruments December 31, 2020 Consolidated Balance Sheet Position September 30, 2020 Consolidated Balance Sheet Position Interest Rate Swaps $ (41.0) Other current liabilities $ (46.3) Other current liabilities Currency Exchange Contracts (2.6) Other current liabilities (0.4) Other current liabilities Cross-Currency Swaps 1.5 Other assets 9.7 Other assets Undesignated Forward Contracts 0.5 Other assets 0.0 Other assets Total $ (41.6) $ (37.0)

Retirement and Postretirement P

Retirement and Postretirement Plans	3 Months Ended
	Dec. 31, 2020
Retirement Benefits [Abstract]
Compensation and Employee Benefit Plans	Retirement and Postretirement Benefit Plans We sponsor five defined benefit retirement plans. Those plans include a master defined benefit retirement plan in the United States, a nonqualified supplemental executive defined benefit retirement plan, and three defined benefit retirement plans covering employees in Germany and France. Benefits for such plans are based primarily on years of service and the employee’s level of compensation in specific periods of employment. We contribute funds to trusts as necessary to provide for current service and for any unfunded projected future benefit obligation over a reasonable period of time. All of our plans have a September 30 measurement date. The following table provides the components of net pension expense for our defined benefit retirement plans. Three Months Ended Consolidated Statements of Income Item 2020 2019 Service cost $ 0.5 $ 0.4 Cost of goods sold Service cost 0.8 0.8 Selling and administrative expenses Interest cost 1.9 2.5 Investment income (expense) and other, net Expected return on plan assets (3.0) (3.7) Investment income (expense) and other, net Amortization of unrecognized prior service cost, net — 0.1 Investment income (expense) and other, net Amortization of net loss 1.5 1.5 Investment income (expense) and other, net Net periodic benefit cost 1.7 1.6 Special termination benefits 1 3.3 — Special charges Net pension expense $ 5.0 $ 1.6 1 In September 2020, we offered certain employees in the United States the option to participate in a voluntary early retirement plan. The employees who accepted the offer received special termination benefits during the three months ended December 31, 2020, which were recorded as a component of Special charges in the Consolidated Statements of Income. See Note 8. Special Charges for further information. In addition to defined benefit retirement plans, we also offer two postretirement health care plans in the United States that provide health care benefits to qualified retirees and their dependents. The plans are closed to new participants and include retiree cost sharing provisions and generally extend retiree coverage for medical and prescription benefits beyond the COBRA continuation period to the date of Medicare eligibility. Annual costs related to these plans are not significant. In connection with the voluntary early retirement plan offered in September 2020, we incurred $0.2 million of special termination benefits related to our postretirement health care plan. The amount was recorded as a recorded as a component of Special charges in the Consolidated Statements of Income. See Note 8. Special Charges for further information. We have defined contribution savings plans that cover substantially all U.S. employees and certain non-U.S. employees. The general purpose of these plans is to provide additional financial security in retirement by providing employees with an incentive to regularly save a portion of their earnings. Our contributions to the plans are based on eligibility and, in some cases, employee contributions. Expense under these plans was $7.8 million and $6.2 million for the quarterly periods ended December 31, 2020 and 2019.

Other Comprehensive Income (Los

Other Comprehensive Income (Loss)	3 Months Ended
	Dec. 31, 2020
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other Comprehensive Income (Loss)	Other Comprehensive Income (Loss) The following tables represent the changes in Other comprehensive income (loss) and Accumulated other comprehensive income (loss) by component for the three months ended December 31, 2020 and 2019: Three Months Ended December 31, 2020 Other comprehensive income (loss) Accumulated other comprehensive income (loss) Prior to Reclassification Pre-tax Tax effect Net of tax Beginning Net activity Ending balance 2 Derivative instruments designated as hedges 1 : Currency exchange contracts $ (1.4) $ (0.8) $ (2.2) $ 0.5 $ (1.7) $ (0.3) $ (1.7) $ (2.0) Interest rate swaps 8.0 (2.6) 5.4 (1.2) 4.2 (35.7) 4.2 (31.5) Cross-currency swaps (9.6) — (9.6) 2.2 (7.4) 6.7 (7.4) (0.7) Derivative instruments designated as hedges total $ (3.0) $ (3.4) $ (6.4) $ 1.5 $ (4.9) $ (29.3) $ (4.9) $ (34.2) Foreign currency translation adjustment 41.3 — 41.3 — 41.3 (110.7) 41.3 (69.4) Change in pension and postretirement defined benefit plans (0.5) 1.2 0.7 (0.2) 0.5 (40.2) 0.5 (39.7) Total $ 37.8 $ (2.2) $ 35.6 $ 1.3 $ 36.9 $ (180.2) $ 36.9 $ (143.3) Three Months Ended December 31, 2019 Other comprehensive income (loss) Accumulated other comprehensive income (loss) Prior to Reclassification Pre-tax Tax effect Net of tax Beginning Net activity Ending balance Derivative instruments designated as hedges 1 : Currency exchange contracts $ (0.3) $ 0.1 $ (0.2) $ — $ (0.2) $ 0.2 $ (0.2) $ — Interest rate swaps 0.9 0.8 1.7 (0.4) 1.3 (5.2) 1.3 (3.9) Cross-currency swaps (4.8) — (4.8) 1.1 (3.7) 12.2 (3.7) 8.5 Derivative instruments designated as hedges total $ (4.2) $ 0.9 $ (3.3) $ 0.7 $ (2.6) $ 7.2 $ (2.6) $ 4.6 Foreign currency translation adjustment 23.1 — 23.1 — 23.1 (145.4) 23.1 (122.3) Change in pension and postretirement defined benefit plans (0.2) 1.2 1.0 (0.3) 0.7 (44.3) 0.7 (43.6) Total $ 18.7 $ 2.1 $ 20.8 $ 0.4 $ 21.2 $ (182.5) $ 21.2 $ (161.3) 1 See Note 5. Derivative Instruments and Hedging Activity for information regarding our hedging strategies. 2 The estimated net amount of gains and losses reported in Accumulated other comprehensive income (loss) related to our derivative instruments designated as hedges as of December 31, 2020 that are expected to be reclassified into earnings within the next 12 months is expense of $8.8 million. The following table represents the items reclassified out of Accumulated other comprehensive income (loss) and the related tax effects for the three months ended December 31, 2020 and 2019: Three Months Ended December 31 2020 2019 Amount Tax effect Net of tax Amount Tax effect Net of tax Derivative instruments designated as hedges: Currency exchange contracts 1 $ (0.8) $ 0.2 $ (0.6) $ 0.1 $ (0.1) $ — Interest rate swaps 2 (2.6) 0.6 (2.0) 0.8 (0.2) 0.6 Derivative instruments designated as hedges total $ (3.4) $ 0.8 $ (2.6) $ 0.9 $ (0.3) $ 0.6 Change in pension and postretirement defined benefit plans 3 $ 1.2 $ (0.2) $ 1.0 $ 1.2 $ (0.3) $ 0.9 1 Reclassified from Accumulated other comprehensive income (loss) into Investment income (expense) and other, net. 2 Reclassified from Accumulated other comprehensive income (loss) into Interest expense.

Special Charges

Special Charges	3 Months Ended
	Dec. 31, 2020
Special Charges [Abstract]
Special Charges	Special Charges Special charges are incurred in connection with various transformative initiatives, exit activities, and organizational changes to improve our business alignment and cost structure. Although these charges are infrequent and unusual in nature, additional Special charges are expected to be incurred. It is not practicable to estimate the amount of these future expected costs until such time as the evaluations are complete. The following table summarizes the Special charges recognized for the three months ended December 31, 2020 and 2019. Special Charges Three Months Ended December 31 2020 2019 Global information technology transformation $ 1.3 $ 4.1 Workforce reduction plan 22.7 — Integration-related activities 3.1 3.2 Site consolidation and other cost optimization activities, including related severance cost — 0.5 Total Special Charges $ 27.1 $ 7.8 Global Information Technology Transformation In fiscal 2019, management initiated a global information technology transformation, including rationalizing and transforming our enterprise resource planning software solutions and other complementary information technology systems. The objective of this initiative is to consolidate and streamline our key workstreams that interact with customers and vendors and support our financial reporting processes while maintaining the security of our data. The solutions designed under this initiative will be implemented over the next five to seven years. Workforce Reduction Plan On September 15, 2020, we committed to a workforce reduction plan as part of the continued business optimization initiatives to advance our strategy and growth platforms and improve our operations and cost structure. The workforce reduction plan includes a voluntary retirement program and involuntary severance actions. For the three months ended December 31, 2020, we incurred $22.7 million related to this initiative within Special charges. Integration-Related Activities We incurred costs, including severance and benefit costs, associated with business realignment and integration activities focused on reducing complexity, increasing efficiency, and improving our cost structure. We acquired several businesses as disclosed within Note 3. Business Combinations within the 2020 Form 10-K for the fiscal year ended September 30, 2020 for which we also continue to incur integration-related costs and severance costs. Site Consolidation and Other Cost Optimization Activities, Including Related Severance Cost We continue to streamline our operations and simplify our supply chain by transforming and consolidating certain manufacturing and distribution operations. For all accrued severance and other benefit charges described above, we record reserves within Other current liabilities. The following table summarizes the reserve activity for severance and other benefits for the three months ended December 31, 2020. Balance as of September 30, 2020 $ 11.3 Expenses 20.0 Cash payments (9.7) Reversals (0.1) Balance as of December 31, 2020 $ 21.5

Income Taxes

Income Taxes	3 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The effective tax rate for the three months ended December 31, 2020 wa s 17.9% com pared to 6.6% for the comparable period in the prior year. The rate was lower in the prior year period primarily due to the favorable impact of excess tax benefits on deductible stock compensation compared to the current year period.

Earnings per Common Share

Earnings per Common Share	3 Months Ended
	Dec. 31, 2020
Earnings Per Share [Abstract]
Earnings per Common Share	Earnings per Common Share Basic earnings per share (“EPS”) is calculated based upon the weighted average number of outstanding common shares for the period, plus the effect of deferred vested shares. Diluted earnings per share is calculated consistent with the basic earnings per share calculation plus the effect of dilutive unissued common shares related to stock-based employee compensation programs. For all periods presented, anti-dilutive stock options were excluded from the calculation of diluted earnings per share. Cumulative treasury stock acquired, less cumulative shares reissued, have been excluded in determining the average number of shares outstanding. Earnings per share are calculated as follows: Three Months Ended December 31 2020 2019 Net Income $ 58.8 $ 39.8 Net Income per Basic Common Share $ 0.88 $ 0.60 Net Income per Diluted Common Share $ 0.88 $ 0.59 Average Basic Common Shares Outstanding (in thousands) 66,497 66,792 Add potential effect of exercise of stock options and other unvested equity awards 428 537 Average Diluted Common Shares Outstanding (in thousands) 66,925 67,329 Shares with anti-dilutive effect excluded from the computation of diluted EPS 639 291

Segment Reporting

Segment Reporting	3 Months Ended
	Dec. 31, 2020
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting We disclose segment information that is consistent with the way in which management operates and views the business. Our operating structure contains the following reportable segments: • Patient Support Systems – globally provides an ecosystem of our digital and connected care solutions: devices, software, communications and integration technologies that improve care and deliver actionable insights to caregivers and patients in the acute care setting. Key products include care communications and mobility solutions, connected med-surg and ICU bed systems, sensors and surfaces, safe patient handling equipment and services. • Front Line Care – globally provides integrated patient monitoring and diagnostic technologies – from hospital to home – that enable and support Hillrom’s connected care strategy. Our diverse portfolio includes secure, connected, digital assessment technologies to help diagnose, treat and manage a wide variety of illnesses and diseases, including respiratory therapy, cardiology, vision screening and physical assessment. • Surgical Solutions – globally enables peak procedural performance, connectivity and video integration products that improve collaboration, workflow, safety and efficiency in the operating room, such as surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. Our performance within each reportable segment continues to be measured on a divisional income basis before non-allocated operating and administrative costs, litigation, special charges, acquisition and integration costs, acquisition-related intangible asset amortization, and other unusual events. Divisional income generally represents the division’s gross profit, excluding acquisition-related intangible asset amortization, less its direct operating costs along with an allocation of manufacturing and distribution costs, research and development, and certain corporate functional expenses. Non-allocated operating costs, administrative costs, and other includes functional expenses that support the entire organization such as administration, finance, legal and human resources, expenses associated with strategic developments, acquisition-related intangible asset amortization, and other events that are not indicative of operating trends. We exclude such amounts from divisional income to allow management to evaluate and understand divisional operating trends. The chief operating decision maker does not receive any asset information by reportable segment and, accordingly, we do not report asset information by reportable segment. Three Months Ended December 31 2020 2019 Net Revenue - United States: Patient Support Systems $ 268.9 $ 266.6 Front Line Care 184.5 178.1 Surgical Solutions 34.2 37.1 Total net revenue - United States $ 487.6 $ 481.8 Net Revenue - Outside of the United States (“OUS”): Patient Support Systems $ 108.5 $ 77.6 Front Line Care 85.4 76.5 Surgical Solutions 59.6 49.1 Total net revenue - OUS $ 253.5 $ 203.2 Net Revenue: Patient Support Systems $ 377.4 $ 344.2 Front Line Care 269.9 254.6 Surgical Solutions 93.8 86.2 Total net revenue $ 741.1 $ 685.0 Divisional Income: Patient Support Systems $ 87.3 $ 58.4 Front Line Care 81.9 73.5 Surgical Solutions 17.5 12.8 Other Operating Costs: Non-allocated operating costs, administrative costs, and other 77.2 58.0 Special charges 27.1 7.8 Operating Profit 82.4 78.9 Interest expense (17.8) (19.4) Loss on extinguishment of debt — (15.6) Investment income (expense) and other, net 7.0 (1.3) Income Before Income Taxes $ 71.6 $ 42.6

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies General We are subject to various claims and contingencies arising out of the normal course of business, including those relating to governmental investigations and proceedings, commercial transactions, product liability, employee related matters, antitrust, safety, health, taxes, environmental and other matters. Litigation is subject to many uncertainties and the outcome of individual litigated matters is not predictable with assurance. It is possible that some litigation matters for which reserves have not been established could be decided unfavorably to us, and that any such unfavorable decisions could have a materially adverse effect on our financial condition, results of operations and cash flows. Self-Insurance We are involved in various claims, including product and general liability, workers’ compensation, auto liability and employment related matters. Such claims in the United States have deductibles and self-insured retentions at various limits up to $1.0 million per occurrence or per claim, depending upon the type of coverage and policy period. International deductibles and self-insured retentions are lower. We are also generally self-insured up to certain stop-loss limits for certain employee health benefits, including medical, drug, and dental. Our policy is to estimate reserves based upon a number of factors including known claims, estimated incurred but not reported claims and outside actuarial analysis, which are based on historical information along with certain assumptions about future events. Such estimated reserves are classified as Other current liabilities and Other long-term liabilities.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies Nature of Operations (Policies)	3 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Recently Issued Accounting Standards	Recently Adopted Accounting Standards In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326) – Measurement of Credit Losses of Financial Instruments and has subsequently issued related amendments, collectively referred to as “Topic 326”. Topic 326 requires entities to measure credit losses for financial assets measured at amortized cost based on expected losses rather than incurred losses. This adoption primarily impacted our trade accounts receivables. Under the current expected credit loss model, we review receivables for collectability based on an assessment of various factors, including historical collection experience for each receivable type and expectations of forward-looking loss estimates, and individual receivables are also reviewed for collectability based on unique circumstances. Any adjustments made to our historical loss experience reflect current differences in asset-specific risk characteristics, including, customer type (public or government entity versus private entity) and geographic location of the customer. We adopted ASU 2016-13 in the first quarter of fiscal 2021 using the modified retrospective transition method with a cumulative effect adjustment directly to retained earnings. The cumulative effect of applying Topic 326 were an increase to the allowance for credit losses of $3.0 million and deferred tax assets of $0.8 million with a corresponding decrease to the opening balance of Retained earnings of $2.2 million. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement . The purpose of the standard is to improve the overall usefulness of fair value disclosures to financial statement users and reduce unnecessary costs to companies when preparing the disclosures. ASU 2018-13 requires the application of the prospective method of transition (for only the most recent interim or annual period presented in the initial fiscal year of adoption) to the new disclosure requirements for (1) changes in unrealized gains and losses included in other comprehensive income and (2) the range and weighted average used to develop significant unobservable inputs for Level 3 fair value measurements. ASU 2018-13 also requires prospective application to any modifications to disclosures made because of the change to the requirements for the narrative description of measurement uncertainty. The effects of all other amendments made by ASU 2018-13 must be applied retrospectively to all periods presented. We adopted ASU 2018-13 in the first quarter of fiscal 2021. The adoption of ASU 2018-13 had no impact on our Condensed Consolidated Financial Statements. In August 2018, the FASB issued ASU 2018-15, Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40) : Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract . This update aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement to be consistent with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). We adopted ASU 2018-15 in the first quarter of fiscal 2021 using the prospective transition method approach. The Company’s cloud computing hosting arrangements are primarily information technology agreements that support the Company’s operations and infrastructure. The adoption of ASU 2018-15 did not have a significant impact on our Condensed Consolidated Financial Statements. In November 2018, the FASB issued ASU 2018-18, Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606 . The purpose of the standard is to (1) clarify that transactions between participants in a collaborative agreement should be accounted for under Topic 606 and (2) add unit-of-account guidance in Topic 808 to align with Topic 606. We retrospectively adopted ASU 2018-18 in the first quarter of fiscal 2021. The adoption of ASU 2018-18 had no impact on our Condensed Consolidated Financial Statements. Recently Issued Accounting Standards In August 2018, the FASB issued ASU 2018-14, Compensation – Retirement Benefits – Defined Benefit Plans – General (Topic 715-20): Disclosure Framework – Changes to the Disclosure Requirements for Defined Benefit Plans. The purpose of the standard is to improve the overall usefulness of defined benefit pension and other postretirement plan disclosures to financial statement users and reduce unnecessary costs to companies when preparing the disclosures. ASU 2018-14 is effective for our annual disclosures for fiscal 2021 and requires a retrospective transition method. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The purpose of the standard is to remove certain exceptions to the general principles of Topic 740: Income Taxes in order to reduce the cost and complexity of its application and to maintain or improve the usefulness of the information provided to users of financial statements. ASU 2019-12 is effective for our first quarter of fiscal 2022 and will be applied either retrospectively or prospectively depending on the specific Topic 740 exception affected. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. Except as noted above, there are no significant changes to our assessment of the impact of recently issued accounting standards included in Note 1. Summary of Significant Accounting Policies of our Condensed Consolidated Financial Statements in our 2020 Form 10-K.
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the SEC for interim unaudited Condensed Consolidated Financial Statements. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete Condensed Consolidated Financial Statements. In the opinion of management, all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying Condensed Consolidated Financial Statements to present fairly the results of the interim periods presented. Quarterly results are not necessarily indicative of annual results. The unaudited Condensed Consolidated Financial Statements appearing in this Quarterly Report on Form 10-Q should be read in conjunction with the audited Condensed Consolidated Financial Statements and notes thereto included in Hillrom’s fiscal 2020 Form 10-K as filed with the SEC. The Condensed Consolidated Financial Statements include the accounts of Hillrom and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. The Company makes a number of significant estimates, assumptions, and judgments in the preparation of its financial statements. Additionally, the Company measures and classifies fair value measurements in accordance with the level hierarchy in conformity with GAAP. As of December 31, 2020, the Company's significant accounting policies and estimates and valuation techniques used to measure fair value have not changed from September 30, 2020. See Note 1. Summary of Significant Accounting Policies within the 2020 Form 10-K for the fiscal year ended September 30, 2020 for further information. Revenue Recognition — Sales and Rentals Disaggregation of Revenue The Company disaggregates revenue recognized from contracts with customers by geography and reportable segments consistent with the way in which management operates and views the business. See Note 11. Segment Reporting for the presentation of the Company's revenue disaggregation. Contract Balances Contract liabilities represent deferred revenues that arise as a result of cash received from customers at inception of contracts or where the timing of billing for services precedes satisfaction of our performance obligations. Such remaining performance obligations represent the portion of the contract price for which work has not been performed and are primarily related to our installation and service contracts. These contract liabilities are recorded in Deferred revenue and Other long-term liabilities. We expect to satisfy the majority of the remaining performance obligations and recognize revenue related to installation and service contracts within 12 to 24 months. The nature of our products and services does not give rise to contract assets as we typically do not have instances where a right to payment for goods and services already transferred to a customer exists that is conditional on something other than the passage of time. The following table summarizes contract liability activity for the three months ended December 31, 2020. The contract liability balance represents the transaction price allocated to the remaining performance obligations. Contract Liabilities Balance as of October 1, 2020 $ 138.1 New revenue deferrals 99.0 Revenue recognized upon satisfaction of performance obligations (97.2) Foreign currency translation adjustment 1.3 Balance as of December 31, 2020 $ 141.2 Rental Revenue We make certain products available to customers under short-term lease arrangements. Rental usage of these products is provided as an alternative to product sales and is short-term in nature. Products primarily include smart beds, including, but not limited to, bariatric, intensive care unit, maternity, and home care beds, as well as surfaces. These lease arrangements provide our customers with our products during periods of peak demand or often times for specialty purposes. Additionally, we provide wearable, non-invasive ventilation products to patients covered by monthly medical insurance reimbursements, which are considered month-to-month leasing arrangements. Income arising from these lease arrangements where we are the lessor is recognized within Rental revenue. We accounted for these lease arrangements as operating leases. Warranties and Guarantees We routinely grant limited warranties on our products with respect to defects in material and workmanship. The terms of these warranties are generally one year; however, certain components and products have substantially longer warranty periods. We recognize a reserve with respect to these obligations at the time of product sale, with subsequent warranty claims recorded directly against the reserve. The amount of the warranty reserve is determined based on historical trend experience for the covered products. For more significant warranty-related matters, which might require a field corrective action, separate reserves are established when such events are identified and the cost of correction can be reasonably estimated. In the normal course of business, we enter into various other guarantees and indemnities in our relationships with suppliers, service providers, customers, business partners and others. Examples of these arrangements would include guarantees of product performance, indemnifications to service providers and indemnifications of our actions to business partners. These guarantees and indemnifications have not historically had a material impact on our financial condition or results of operations, nor do we expect them to although indemnifications associated with our actions generally have no dollar limitations. In conjunction with our acquisition and divestiture activities, we entered into select guarantees and indemnifications of performance with respect to the fulfillment of our commitments under applicable purchase and sale agreements. The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract. With respect to divestitures, we also routinely enter into non-competition agreements for varying periods of time. Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have an adverse impact on our Condensed Consolidated Financial Statements. The following summarizes accrued product warranty activity for the three months ended December 31, 2020: Three Months Ended December 31 2020 Balance as of beginning of period $ 30.8 Provision for warranties in the period 5.4 Warranty claims in the period (6.4) Foreign currency translation adjustment 0.2 Balance as of end of period $ 30.0 Government Programs Related to COVID-19

Supplementary Balance Sheet I_2

Supplementary Balance Sheet Information (Tables)	3 Months Ended
	Dec. 31, 2020
Balance Sheet Related Disclosures [Abstract]
Supplementary Balance Sheet Information	December 31, September 30, 2020 Inventories, net of reserves: Finished products $ 156.1 $ 167.6 Work in process 51.7 48.4 Raw materials 128.1 136.0 Total inventories, net of reserves $ 335.9 $ 352.0 Accumulated amortization of software and other intangible assets $ 703.6 $ 667.3 Investments included in Other assets $ 50.5 $ 49.0
Schedule of Cash Flow, Supplemental Disclosures	Supplemental Cash Flow Information Three Months Ended 2020 2019 Non-cash operating activities Operating cash flows paid for amounts included in the measurement of lease liabilities $ 7.0 $ 7.1 Non-cash investing activities: Change in capital expenditures not paid $ (4.2) $ (1.8) Non-cash financing activities: Distribution of shares issued under stock-based compensation plans $ 31.7 $ 25.1 Non-cash investing and financing activities: Right of use assets obtained in exchange for new lease liabilities $ 1.8 $ 6.5

Financing Agreements (Tables)

Financing Agreements (Tables)	3 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Schedule of Fair Values of Long-Term Debt Instruments	The estimated fair values of our long-term debt instruments are described in the table below: December 31, September 30, 2020 Senior unsecured 5.00% notes due on February 15, 2025 $ 309.3 $ 310.1 Senior unsecured 4.375% notes due on September 15, 2027 450.0 441.2 Unsecured debentures 47.9 48.0 Total $ 807.2 $ 799.3

Derivatives (Tables)

Derivatives (Tables)	3 Months Ended
	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	Three Months Ended December 31 2020 2019 Unrealized gain $ 0.5 $ 0.2 Realized gain 2.1 0.4 Fair Value We classify fair value measurements on our derivative instruments as Level 2. The estimated fair values of our derivative instruments are described in the table below: Derivative Instruments December 31, 2020 Consolidated Balance Sheet Position September 30, 2020 Consolidated Balance Sheet Position Interest Rate Swaps $ (41.0) Other current liabilities $ (46.3) Other current liabilities Currency Exchange Contracts (2.6) Other current liabilities (0.4) Other current liabilities Cross-Currency Swaps 1.5 Other assets 9.7 Other assets Undesignated Forward Contracts 0.5 Other assets 0.0 Other assets Total $ (41.6) $ (37.0)
Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location

Retirement and Postretirement_2

Retirement and Postretirement Plans (Tables)	3 Months Ended
	Dec. 31, 2020
Retirement Benefits [Abstract]
Schedule of Components of Net Pension Expense	The following table provides the components of net pension expense for our defined benefit retirement plans. Three Months Ended Consolidated Statements of Income Item 2020 2019 Service cost $ 0.5 $ 0.4 Cost of goods sold Service cost 0.8 0.8 Selling and administrative expenses Interest cost 1.9 2.5 Investment income (expense) and other, net Expected return on plan assets (3.0) (3.7) Investment income (expense) and other, net Amortization of unrecognized prior service cost, net — 0.1 Investment income (expense) and other, net Amortization of net loss 1.5 1.5 Investment income (expense) and other, net Net periodic benefit cost 1.7 1.6 Special termination benefits 1 3.3 — Special charges Net pension expense $ 5.0 $ 1.6 1 In September 2020, we offered certain employees in the United States the option to participate in a voluntary early retirement plan. The employees who accepted the offer received special termination benefits during the three months ended December 31, 2020, which were recorded as a component of Special charges in the Consolidated Statements of Income. See Note 8. Special Charges for further information.

Other Comprehensive Income (L_2

Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Dec. 31, 2020
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Changes in AOCL by Component	The following tables represent the changes in Other comprehensive income (loss) and Accumulated other comprehensive income (loss) by component for the three months ended December 31, 2020 and 2019: Three Months Ended December 31, 2020 Other comprehensive income (loss) Accumulated other comprehensive income (loss) Prior to Reclassification Pre-tax Tax effect Net of tax Beginning Net activity Ending balance 2 Derivative instruments designated as hedges 1 : Currency exchange contracts $ (1.4) $ (0.8) $ (2.2) $ 0.5 $ (1.7) $ (0.3) $ (1.7) $ (2.0) Interest rate swaps 8.0 (2.6) 5.4 (1.2) 4.2 (35.7) 4.2 (31.5) Cross-currency swaps (9.6) — (9.6) 2.2 (7.4) 6.7 (7.4) (0.7) Derivative instruments designated as hedges total $ (3.0) $ (3.4) $ (6.4) $ 1.5 $ (4.9) $ (29.3) $ (4.9) $ (34.2) Foreign currency translation adjustment 41.3 — 41.3 — 41.3 (110.7) 41.3 (69.4) Change in pension and postretirement defined benefit plans (0.5) 1.2 0.7 (0.2) 0.5 (40.2) 0.5 (39.7) Total $ 37.8 $ (2.2) $ 35.6 $ 1.3 $ 36.9 $ (180.2) $ 36.9 $ (143.3) Three Months Ended December 31, 2019 Other comprehensive income (loss) Accumulated other comprehensive income (loss) Prior to Reclassification Pre-tax Tax effect Net of tax Beginning Net activity Ending balance Derivative instruments designated as hedges 1 : Currency exchange contracts $ (0.3) $ 0.1 $ (0.2) $ — $ (0.2) $ 0.2 $ (0.2) $ — Interest rate swaps 0.9 0.8 1.7 (0.4) 1.3 (5.2) 1.3 (3.9) Cross-currency swaps (4.8) — (4.8) 1.1 (3.7) 12.2 (3.7) 8.5 Derivative instruments designated as hedges total $ (4.2) $ 0.9 $ (3.3) $ 0.7 $ (2.6) $ 7.2 $ (2.6) $ 4.6 Foreign currency translation adjustment 23.1 — 23.1 — 23.1 (145.4) 23.1 (122.3) Change in pension and postretirement defined benefit plans (0.2) 1.2 1.0 (0.3) 0.7 (44.3) 0.7 (43.6) Total $ 18.7 $ 2.1 $ 20.8 $ 0.4 $ 21.2 $ (182.5) $ 21.2 $ (161.3) 1 See Note 5. Derivative Instruments and Hedging Activity for information regarding our hedging strategies. 2 The estimated net amount of gains and losses reported in Accumulated other comprehensive income (loss) related to our derivative instruments designated as hedges as of December 31, 2020 that are expected to be reclassified into earnings within the next 12 months is expense of $8.8 million.
Schedule of Items Reclassified out of AOCL	The following table represents the items reclassified out of Accumulated other comprehensive income (loss) and the related tax effects for the three months ended December 31, 2020 and 2019: Three Months Ended December 31 2020 2019 Amount Tax effect Net of tax Amount Tax effect Net of tax Derivative instruments designated as hedges: Currency exchange contracts 1 $ (0.8) $ 0.2 $ (0.6) $ 0.1 $ (0.1) $ — Interest rate swaps 2 (2.6) 0.6 (2.0) 0.8 (0.2) 0.6 Derivative instruments designated as hedges total $ (3.4) $ 0.8 $ (2.6) $ 0.9 $ (0.3) $ 0.6 Change in pension and postretirement defined benefit plans 3 $ 1.2 $ (0.2) $ 1.0 $ 1.2 $ (0.3) $ 0.9 1 Reclassified from Accumulated other comprehensive income (loss) into Investment income (expense) and other, net. 2 Reclassified from Accumulated other comprehensive income (loss) into Interest expense.

Special Charges (Tables)

Special Charges (Tables)	3 Months Ended
	Dec. 31, 2020
Special Charges [Abstract]
Restructuring Activity	three months ended December 31, 2020. Balance as of September 30, 2020 $ 11.3 Expenses 20.0 Cash payments (9.7) Reversals (0.1) Balance as of December 31, 2020 $ 21.5
Special Charges, Net	The following table summarizes the Special charges recognized for the three months ended December 31, 2020 and 2019. Special Charges Three Months Ended December 31 2020 2019 Global information technology transformation $ 1.3 $ 4.1 Workforce reduction plan 22.7 — Integration-related activities 3.1 3.2 Site consolidation and other cost optimization activities, including related severance cost — 0.5 Total Special Charges $ 27.1 $ 7.8

Earnings per Common Share (Tabl

Earnings per Common Share (Tables)	3 Months Ended
	Dec. 31, 2020
Earnings Per Share [Abstract]
Calculated Earnings per Share	Earnings per share are calculated as follows: Three Months Ended December 31 2020 2019 Net Income $ 58.8 $ 39.8 Net Income per Basic Common Share $ 0.88 $ 0.60 Net Income per Diluted Common Share $ 0.88 $ 0.59 Average Basic Common Shares Outstanding (in thousands) 66,497 66,792 Add potential effect of exercise of stock options and other unvested equity awards 428 537 Average Diluted Common Shares Outstanding (in thousands) 66,925 67,329 Shares with anti-dilutive effect excluded from the computation of diluted EPS 639 291

Segment Reporting (Tables)

Segment Reporting (Tables)	3 Months Ended
	Dec. 31, 2020
Segment Reporting [Abstract]
Reconciliation of Segment Information to Consolidated Financial Information	Three Months Ended December 31 2020 2019 Net Revenue - United States: Patient Support Systems $ 268.9 $ 266.6 Front Line Care 184.5 178.1 Surgical Solutions 34.2 37.1 Total net revenue - United States $ 487.6 $ 481.8 Net Revenue - Outside of the United States (“OUS”): Patient Support Systems $ 108.5 $ 77.6 Front Line Care 85.4 76.5 Surgical Solutions 59.6 49.1 Total net revenue - OUS $ 253.5 $ 203.2 Net Revenue: Patient Support Systems $ 377.4 $ 344.2 Front Line Care 269.9 254.6 Surgical Solutions 93.8 86.2 Total net revenue $ 741.1 $ 685.0 Divisional Income: Patient Support Systems $ 87.3 $ 58.4 Front Line Care 81.9 73.5 Surgical Solutions 17.5 12.8 Other Operating Costs: Non-allocated operating costs, administrative costs, and other 77.2 58.0 Special charges 27.1 7.8 Operating Profit 82.4 78.9 Interest expense (17.8) (19.4) Loss on extinguishment of debt — (15.6) Investment income (expense) and other, net 7.0 (1.3) Income Before Income Taxes $ 71.6 $ 42.6

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Sep. 30, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Selling and administrative expenses	$ 209,000,000	$ 196,800,000
Acquisition-related intangible asset amortization	25,900,000	$ 26,700,000
Cares Act	21,200,000
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax	200,000
Standard Product Warranty Accrual, Increase for Warranties Issued	5,400,000
Standard Product Warranty Accrual, Decrease for Payments	(6,400,000)
Retained Earnings (Accumulated Deficit)	2,174,100,000		$ 2,132,200,000
Accounting Standards Update 2016-13 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Deferred Tax Assets, Valuation Allowance	800,000
Retained Earnings (Accumulated Deficit)	3,000,000
Accounting Standards Update 2016-13 [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Retained Earnings (Accumulated Deficit)	$ 2,200,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Other Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Sep. 30, 2020
Accounting Policies [Abstract]
Revenues	$ 741.1	$ 685
Net Income (Loss) Attributable to Parent	58.8	39.8
Net Income	$ 58.8	$ 39.8
Net Income Attributable to Common Shareholders per Common Share - Basic (usd per share)	$ 0.88	$ 0.60
Earnings Per Share, Diluted	$ 0.88	$ 0.59
Other Liabilities and Deferred Revenue, Noncurrent	$ 141.2		$ 138.1
Deferred Revenue, Additions	99
Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized	(97.2)
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax	$ 1.3

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2020	Sep. 30, 2020
Revenue from Contract with Customer [Abstract]
Other Liabilities and Deferred Revenue, Noncurrent	$ 141.2	$ 138.1
Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized	(97.2)
Deferred Revenue	112.3	$ 110.1
Deferred Revenue, Additions	99
Capitalized Contract Cost [Line Items]
Deferred Revenue, Additions	$ 99

Supplementary Balance Sheet I_3

Supplementary Balance Sheet Information (Details) - USD ($)	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Sep. 30, 2020
Inventories, net of reserves:
Finished products	$ 156,100,000		$ 167,600,000
Inventory, Work in Process, Gross	51,700,000		48,400,000
Inventory, Raw Materials, Net of Reserves	128,100,000		136,000,000
Total inventories, net of reserves	335,900,000		352,000,000
Accumulated amortization of software and other intangible assets	703.6		667,300,000
Investments	50,500,000		$ 49,000,000
Capital Expenditures Incurred but Not yet Paid	(4,200,000)	$ (1,800,000)
Restricted Stock or Unit Expense	31,700,000	25,100,000
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	1,800,000	6,500,000
Operating Lease, Payments	$ 7,000,000	$ 7,100,000

Business Combinations Acquisiti

Business Combinations Acquisitions (Details) - USD ($)	Jan. 27, 2021	Jan. 15, 2021	Dec. 31, 2020	Dec. 31, 2019	Jan. 15, 2022	Sep. 30, 2020
Business Acquisition, Contingent Consideration [Line Items]
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability				$ 8,400,000
Goodwill			$ 1,847,900,000			$ 1,835,500,000
Selling, General and Administrative Expenses [Member] | Excel Medical
Business Acquisition, Contingent Consideration [Line Items]
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability			$ 1,700,000
Bardy [Member] | Bardy [Member]
Business Acquisition, Contingent Consideration [Line Items]
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low		$ 45,000,000			$ 70,000,000
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High		57,000,000			$ 89,000,000
Payments to Acquire Businesses, Gross		$ 375,000,000
Evergreen [Member] | Evergreen [Member]
Business Acquisition, Contingent Consideration [Line Items]
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	$ 10,000,000
Payments to Acquire Businesses, Gross	30,000,000
Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination	25,500,000
Business Combination, Consideration Transferred, Other	$ 2,000,000

Financing Agreements (Schedule

Financing Agreements (Schedule of Total Debt) (Details) - USD ($)	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Sep. 30, 2020	May 01, 2020	Oct. 07, 2019
Debt Instrument [Line Items]
Repayments of Long-term Debt	$ (12,500,000)	$ (12,600,000)
Long-term Debt, by Current and Noncurrent [Abstract]
Unsecured debenture interest rate					4.375%
Debt Instrument, Face Amount					$ 425,000,000
Revolving credit facility, matures September 2021	222,300,000		$ 222,300,000
Total Long-term debt	1,643,800,000		$ 1,655,700,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Letters of Credit Outstanding, Amount	9,000,000
Long-term Debt, by Current and Noncurrent [Abstract]
Line of Credit Facility, Maximum Borrowing Capacity	1,191,000,000
Senior Unsecured 5.00% Notes due on February 14, 2025 [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Unsecured debenture interest rate			5.00%
Securitization Program [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Revolving credit facility, matures September 2021	82,200,000
Debt Instrument, Face Amount				$ 110,000,000
Note Securitization Facility [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Revolving credit facility, matures September 2021	$ 90,000,000
Debt Instrument, Face Amount				$ 90,000,000

Financing Agreements (Narrative

Financing Agreements (Narrative) (Details) - USD ($)	May 01, 2020	Oct. 07, 2019	Dec. 31, 2020	Dec. 31, 2019	Sep. 30, 2020
Debt Instrument [Line Items]
Payment of long-term debt			$ (12,500,000)	$ (12,600,000)
Aggregate value of debt		$ 425,000,000
Unsecured debenture interest rate		4.375%
Payment for Debt Extinguishment or Debt Prepayment Cost		$ 12,200,000	0	(437,200,000)
Gain (Loss) on Extinguishment of Debt			0	15,600,000
Securitization Program [Member]
Debt Instrument [Line Items]
Debt Instrument, Term	364 days
Revolving credit facility, matures September 2021			82,200,000
Aggregate value of debt	$ 110,000,000
Note Securitization Facility [Member]
Debt Instrument [Line Items]
Debt Instrument, Term	364 days
Revolving credit facility, matures September 2021			90,000,000
Aggregate value of debt	$ 90,000,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Senior revolving credit facility, maximum borrowing amount			1,191,000,000
Outstanding letters of credit			$ 9,000,000
Senior Unsecured 5.75% Notes due on September 1, 2023 [Member]
Debt Instrument [Line Items]
Payment for Debt Extinguishment or Debt Prepayment Cost				12,200,000
Gain (Loss) on Extinguishment of Debt				15,600,000
Write off of Deferred Debt Issuance Cost				$ 3,400,000
Senior Unsecured 5.00% Notes due on February 14, 2025 [Member]
Debt Instrument [Line Items]
Unsecured debenture interest rate					5.00%
Senior Unsecured 4.375% Notes due September 2027 [Member]
Debt Instrument [Line Items]
Unsecured debenture interest rate					4.375%

Financing Agreements (Schedul_2

Financing Agreements (Schedule of Fair Value) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Sep. 30, 2020	Oct. 07, 2019
Debt Instrument [Line Items]
Total	$ 807.2	$ 799.3
Unsecured debenture interest rate			4.375%
Unsecured Debentures [Member]
Debt Instrument [Line Items]
Fair value of unsecured notes	47.9	48
Senior Unsecured 5.00% Notes due on February 14, 2025 [Member]
Debt Instrument [Line Items]
Fair value of unsecured notes	309.3	$ 310.1
Unsecured debenture interest rate		5.00%
Senior Unsecured 4.375% Notes due September 2027 [Member]
Debt Instrument [Line Items]
Fair value of unsecured notes	$ 450	$ 441.2
Unsecured debenture interest rate		4.375%

Derivatives (Details)

Derivatives (Details) - USD ($)	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Sep. 30, 2020
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Fair Value, Net	$ (41,600,000)		$ (37,000,000)
Cash Flow Hedging [Member] | Other Current Liabilities [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Fair Value, Net	(41,000,000)		(46,300,000)
Currency Swap [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	42,200,000		64,400,000
Currency Swap [Member] | Other Current Liabilities [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Fair Value, Net	(2,600,000)
Currency Swap [Member] | Other Current Assets [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Fair Value, Net			(400,000)
Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	157,500,000		169,900,000
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	500,000	$ 200,000
Derivative, Gain on Derivative	2,100,000
Derivative, Loss on Derivative		$ 400,000
Not Designated as Hedging Instrument [Member] | Other Assets [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Fair Value, Net	500,000		0
Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	750,000,000
Net Investment Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	198,300,000
Net Investment Hedging [Member] | Other Assets [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Fair Value, Net	1,500,000		$ 9,700,000
Net Investment Hedging [Member] | Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	$ 1,300,000

Leases (Details)

Leases (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Rental expenses	$ 37.7	$ 37

Retirement and Postretirement_3

Retirement and Postretirement Plans (Defined Benefit Plans) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]
Interest cost	$ 1.9	$ 2.5
Expected return on plan assets	(3)	(3.7)
Defined Benefit Plan, Amortization of Prior Service Cost (Credit)	0	0.1
Amortization of net loss	1.5	1.5
Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Remeasurement due to Settlement	3.3
Net pension expense	5	1.6
Defined contribution savings plans expense	7.8	6.2
Cost of Goods and Service Benchmark [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.5	0.4
Selling, General and Administrative Expenses [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 0.8	$ 0.8

Retirement and Postretirement_4

Retirement and Postretirement Plans (Defined Contribution Plans) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Retirement Benefits [Abstract]
Defined contribution savings plans expense	$ 7.8	$ 6.2

Other Comprehensive Income (L_3

Other Comprehensive Income (Loss) (Schedule of Changes in AOCL by Component) (Details) - USD ($)	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	$ 8,800,000
Other comprehensive income (loss)
Other Comprehensive Income (Loss), Net of Tax, Total	36,900,000	$ 21,200,000
Accumulated other comprehensive loss
Beginning balance	1,726,100,000
Net activity	36,900,000	21,200,000
Ending balance	1,763,100,000
Income Tax Expense (Benefit)	12,800,000	2,800,000
Net Income (Loss) Attributable to Parent	58,800,000	39,800,000
Available-for-sale Securities and Hedges [Member]
Other comprehensive income (loss)
Prior to reclassification	(3,000,000)	(4,200,000)
Reclassification from	(3,400,000)	900,000
Pre-tax	(6,400,000)	(3,300,000)
Tax effect	1,500,000	700,000
Other Comprehensive Income (Loss), Net of Tax, Total	(4,900,000)	(2,600,000)
Accumulated other comprehensive loss
Beginning balance	(29,300,000)	7,200,000
Net activity	(4,900,000)	(2,600,000)
Ending balance	(34,200,000)	4,600,000
Net Income (Loss) Attributable to Parent	2,600,000	(600,000)
Foreign Currency Translation Adjustment [Member]
Other comprehensive income (loss)
Prior to reclassification	41,300,000	23,100,000
Reclassification from	0	0
Pre-tax	41,300,000	23,100,000
Tax effect	0	0
Other Comprehensive Income (Loss), Net of Tax, Total	41,300,000	23,100,000
Accumulated other comprehensive loss
Beginning balance	(110,700,000)	(145,400,000)
Net activity	41,300,000	23,100,000
Ending balance	(69,400,000)	(122,300,000)
Change in Pension and Postretirement Defined Benefit Plans [Member]
Other comprehensive income (loss)
Prior to reclassification	(500,000)	(200,000)
Reclassification from	1,200,000	1,200,000
Pre-tax	700,000	1,000,000
Tax effect	200,000	300,000
Other Comprehensive Income (Loss), Net of Tax, Total	500,000	700,000
Accumulated other comprehensive loss
Beginning balance	(40,200,000)	(44,300,000)
Net activity	500,000	700,000
Ending balance	(39,700,000)	(43,600,000)
Income Tax Expense (Benefit)	(200,000)	(300,000)
Change in Pension and Postretirement Defined Benefit Plans [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Accumulated other comprehensive loss
Net Income (Loss) Attributable to Parent	(1,000,000)	(900,000)
Accumulated Other Comprehensive Income (Loss) [Member]
Other comprehensive income (loss)
Prior to reclassification	37,800,000	18,700,000
Reclassification from	(2,200,000)	2,100,000
Pre-tax	35,600,000	20,800,000
Tax effect	1,300,000	400,000
Other Comprehensive Income (Loss), Net of Tax, Total	36,900,000	21,200,000
Accumulated other comprehensive loss
Beginning balance	(180,200,000)	(182,500,000)
Net activity	36,900,000	21,200,000
Ending balance	(143,300,000)	(161,300,000)
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Other comprehensive income (loss)
Reclassification from	3,400,000	(900,000)
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent | Reclassification out of Accumulated Other Comprehensive Income [Member]
Accumulated other comprehensive loss
Income Tax Expense (Benefit)	800,000	(300,000)
Foreign Exchange Forward [Member] | Available-for-sale Securities and Hedges [Member]
Other comprehensive income (loss)
Pre-tax	(2,200,000)	(200,000)
Other Comprehensive Income (Loss), Net of Tax, Total	(1,700,000)	(200,000)
Accumulated other comprehensive loss
Beginning balance	(300,000)	200,000
Net activity	(1,700,000)	(200,000)
Ending balance	(2,000,000)	0
Foreign Exchange Forward [Member] | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Other comprehensive income (loss)
Tax effect	(500,000)	0
Interest Rate Swap [Member] | Available-for-sale Securities and Hedges [Member]
Other comprehensive income (loss)
Pre-tax	5,400,000	1,700,000
Other Comprehensive Income (Loss), Net of Tax, Total	4,200,000	1,300,000
Accumulated other comprehensive loss
Beginning balance	(35,700,000)	(5,200,000)
Net activity	4,200,000	1,300,000
Ending balance	(31,500,000)	(3,900,000)
Interest Rate Swap [Member] | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Other comprehensive income (loss)
Prior to reclassification	8,000,000	900,000
Reclassification from	2,600,000	(800,000)
Tax effect	1,200,000	400,000
Accumulated other comprehensive loss
Income Tax Expense (Benefit)	600,000	(200,000)
Net Income (Loss) Attributable to Parent	(2,000,000)	600,000
Currency Swap [Member] | Available-for-sale Securities and Hedges [Member]
Accumulated other comprehensive loss
Beginning balance	6,700,000	12,200,000
Currency Swap [Member] | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Other comprehensive income (loss)
Prior to reclassification	(9,600,000)	(4,800,000)
Reclassification from	0	0
Tax effect	(2,200,000)	(1,100,000)
Foreign Exchange Contract [Member] | Available-for-sale Securities and Hedges [Member]
Other comprehensive income (loss)
Pre-tax	(9,600,000)	(4,800,000)
Other Comprehensive Income (Loss), Net of Tax, Total	(7,400,000)	(3,700,000)
Accumulated other comprehensive loss
Net activity	(7,400,000)	(3,700,000)
Ending balance	(700,000)	8,500,000
Foreign Exchange | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Other comprehensive income (loss)
Prior to reclassification	(1,400,000)	(300,000)
Reclassification from	800,000	(100,000)
Accumulated other comprehensive loss
Income Tax Expense (Benefit)	200,000	(100,000)
Net Income (Loss) Attributable to Parent	$ (600,000)	$ 0

Other Comprehensive Income (L_4

Other Comprehensive Income (Loss) (Schedule of Items Reclassified out of AOCL) (Details) - USD ($)	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Sep. 30, 2020	Sep. 30, 2019
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amount reclassified	$ (71,600,000)	$ (42,600,000)
Tax effect	12,800,000	2,800,000
Net of tax	(58,800,000)	(39,800,000)
Net activity	36,900,000	21,200,000
Stockholders' Equity Attributable to Parent	1,763,100,000		$ 1,726,100,000
Available-for-sale Securities and Hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	(3,400,000)	900,000
Net of tax	(2,600,000)	600,000
Prior to reclassification	(3,000,000)	(4,200,000)
Other Comprehensive Income (Loss), before Tax	(6,400,000)	(3,300,000)
Other Comprehensive Income (Loss), Tax	(1,500,000)	(700,000)
Net activity	(4,900,000)	(2,600,000)
Stockholders' Equity Attributable to Parent	(34,200,000)	4,600,000	(29,300,000)	$ 7,200,000
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	0	0
Prior to reclassification	41,300,000	23,100,000
Other Comprehensive Income (Loss), before Tax	41,300,000	23,100,000
Other Comprehensive Income (Loss), Tax	0	0
Net activity	41,300,000	23,100,000
Stockholders' Equity Attributable to Parent	(69,400,000)	(122,300,000)	(110,700,000)	(145,400,000)
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	1,200,000	1,200,000
Tax effect	(200,000)	(300,000)
Prior to reclassification	(500,000)	(200,000)
Other Comprehensive Income (Loss), before Tax	700,000	1,000,000
Other Comprehensive Income (Loss), Tax	(200,000)	(300,000)
Net activity	500,000	700,000
Stockholders' Equity Attributable to Parent	(39,700,000)	(43,600,000)	(40,200,000)	(44,300,000)
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	3,400,000	(900,000)
Accumulated Other Comprehensive Income (Loss) [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	(2,200,000)	2,100,000
Prior to reclassification	37,800,000	18,700,000
Other Comprehensive Income (Loss), before Tax	35,600,000	20,800,000
Other Comprehensive Income (Loss), Tax	(1,300,000)	(400,000)
Net activity	36,900,000	21,200,000
Stockholders' Equity Attributable to Parent	(143,300,000)	(161,300,000)	(180,200,000)	(182,500,000)
Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net of tax	1,000,000	900,000
Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Tax effect	800,000	(300,000)
Foreign Exchange Forward [Member] | Available-for-sale Securities and Hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive Income (Loss), before Tax	(2,200,000)	(200,000)
Net activity	(1,700,000)	(200,000)
Stockholders' Equity Attributable to Parent	(2,000,000)	0	(300,000)	200,000
Foreign Exchange Forward [Member] | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive Income (Loss), Tax	500,000	0
Interest Rate Swap [Member] | Available-for-sale Securities and Hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive Income (Loss), before Tax	5,400,000	1,700,000
Net activity	4,200,000	1,300,000
Stockholders' Equity Attributable to Parent	(31,500,000)	(3,900,000)	(35,700,000)	(5,200,000)
Interest Rate Swap [Member] | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	2,600,000	(800,000)
Tax effect	600,000	(200,000)
Net of tax	2,000,000	(600,000)
Prior to reclassification	8,000,000	900,000
Other Comprehensive Income (Loss), Tax	(1,200,000)	(400,000)
Foreign Exchange | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	800,000	(100,000)
Tax effect	200,000	(100,000)
Net of tax	600,000	0
Prior to reclassification	(1,400,000)	(300,000)
Currency Swap [Member] | Available-for-sale Securities and Hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Stockholders' Equity Attributable to Parent			$ 6,700,000	$ 12,200,000
Currency Swap [Member] | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	0	0
Prior to reclassification	(9,600,000)	(4,800,000)
Other Comprehensive Income (Loss), Tax	2,200,000	1,100,000
Foreign Exchange Contract [Member] | Available-for-sale Securities and Hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive Income (Loss), before Tax	(9,600,000)	(4,800,000)
Net activity	(7,400,000)	(3,700,000)
Stockholders' Equity Attributable to Parent	$ (700,000)	$ 8,500,000

Special Charges (Narrative) (De

Special Charges (Narrative) (Details) - USD ($)	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Restructuring Cost and Reserve [Line Items]
Special charges	$ 27,100,000	$ 7,800,000
Restructuring charges	20,000,000
Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Special charges	3,100,000	3,200,000
Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Special charges	22,700,000
Site Consolidation [Member]
Restructuring Cost and Reserve [Line Items]
Special charges		500,000
Global Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Special charges	$ 1,300,000	$ 4,100,000

Special Charges (Schedule of Re

Special Charges (Schedule of Restructuring Activity) (Details) - USD ($)	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Restructuring Cost and Reserve [Line Items]
Beginning Balance	$ 11,300,000
Expenses	20,000,000
Cash payments	(9,700,000)
Restructuring Reserve, Accrual Adjustment	(100,000)
Ending Balance	21,500,000
Special charges	27,100,000	$ 7,800,000
Global Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Special charges	1,300,000	4,100,000
Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Special charges	3,100,000	$ 3,200,000
Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Special charges	$ 22,700,000

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Effective tax rate	17.90%	6.60%
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability		$ 8.4

Earnings per Common Share (Deta

Earnings per Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Earnings Per Share [Abstract]
Net Income (Loss) Attributable to Parent	$ 58.8	$ 39.8
Net income attributable to common shareholders per common share - Basic (usd per share)	$ 0.88	$ 0.60
Net income attributable to common shareholders per common share - Diluted (usd per share)	$ 0.88	$ 0.59
Average Common Shares Outstanding - Basic (in shares)	66,497	66,792
Add potential effect of exercise of stock options and other unvested equity awards (in shares)	428	537
Average shares outstanding - Diluted (in shares)	66,925	67,329
Shares with anti-dilutive effect excluded from the computation of Diluted EPS (in shares)	639	291

Common Stock (Details)

Common Stock (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Class of Stock Disclosures [Abstract]
Share-based Payment Arrangement, Noncash Expense	$ 11	$ 8.3

Common Stock Common Stock (Shar

Common Stock Common Stock (Share Repurchase Program) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Equity, Class of Treasury Stock [Line Items]
Payments for Repurchase of Common Stock	$ (47.4)	$ 0

Common Stock Common Stock (Narr

Common Stock Common Stock (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Payment, Tax Withholding, Share-based Payment Arrangement	$ (8.3)	$ (15.1)
Payments for Repurchase of Common Stock	$ (47.4)	$ 0

Guarantees (Details)

Guarantees (Details) $ in Millions	3 Months Ended
	Dec. 31, 2020USD ($)
Movement in Standard Product Warranty Accrual [Roll Forward]
Balance at beginning of period	$ 30.8
Standard Product Warranty Accrual, Increase for Warranties Issued	5.4
Standard Product Warranty Accrual, Decrease for Payments	6.4
Balance at end of period	$ 30

Segment Reporting (Details)

Segment Reporting (Details) - USD ($)	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Revenues	$ 741,100,000	$ 685,000,000
Special charges	27,100,000	7,800,000
Operating profit	82,400,000	78,900,000
Interest expense	17,800,000	19,400,000
Gain (Loss) on Extinguishment of Debt	0	(15,600,000)
Investment income (expense) and other, net	7,000,000	(1,300,000)
Income Before Income Taxes	71,600,000	42,600,000
Corporate and Other [Member]
Segment Reporting Information [Line Items]
Non-allocated operating costs, administrative and other	77,200,000	58,000,000
Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues	741,100,000	685,000,000
Operating Segments [Member] | Patient Support Systems [Member]
Segment Reporting Information [Line Items]
Revenues	377,400,000	344,200,000
Divisional Income	87,300,000	58,400,000
Operating Segments [Member] | Front Line Care [Member]
Segment Reporting Information [Line Items]
Revenues	269,900,000	254,600,000
Divisional Income	81,900,000	73,500,000
Operating Segments [Member] | Surgical Solutions [Member]
Segment Reporting Information [Line Items]
Revenues	93,800,000	86,200,000
Divisional Income	17,500,000	12,800,000
Geographic Distribution, Domestic [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues	487,600,000	481,800,000
Geographic Distribution, Domestic [Member] | Operating Segments [Member] | Patient Support Systems [Member]
Segment Reporting Information [Line Items]
Revenues	268,900,000	266,600,000
Geographic Distribution, Domestic [Member] | Operating Segments [Member] | Front Line Care [Member]
Segment Reporting Information [Line Items]
Revenues	184,500,000	178,100,000
Geographic Distribution, Domestic [Member] | Operating Segments [Member] | Surgical Solutions [Member]
Segment Reporting Information [Line Items]
Revenues	34,200,000	37,100,000
Non-US [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues	253,500,000	203,200,000
Non-US [Member] | Operating Segments [Member] | Patient Support Systems [Member]
Segment Reporting Information [Line Items]
Revenues	108,500,000	77,600,000
Non-US [Member] | Operating Segments [Member] | Front Line Care [Member]
Segment Reporting Information [Line Items]
Revenues	85,400,000	76,500,000
Non-US [Member] | Operating Segments [Member] | Surgical Solutions [Member]
Segment Reporting Information [Line Items]
Revenues	$ 59,600,000	$ 49,100,000

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	Dec. 31, 2020USD ($)
Uninsured Risk [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Deductibles and self-insured retentions	$ 1

Uncategorized Items - hrc-20201

Label	Element	Value
Common Stock [Member]
Common Stock, Shares, Outstanding	us-gaap_CommonStockSharesOutstanding	88,457,634
Common Stock, Shares, Outstanding	us-gaap_CommonStockSharesOutstanding	88,457,634